Illinois Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 37 (82% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 16,424
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 75.84%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 945
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 60.95%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 20.86% 31.32%
White, Hispanic/Latino Patients 27.66% 18.62%
Black/African American, Non-Hispanic/Latino Patients 21.02% 17.57%
Black/African American, Hispanic/Latino Patients 0.49% 0.32%
Asian Patients3 1.27% 0.53%
American Indian/Alaska Native Patients3 1.05% 0.63%
Native Hawaiian/Other Pacific Islander Patients3 0.15% 0.21%
Patients with More than one race3 1.13% 0.74%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 12.69% 10.26%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.25% 2.33%
Unreported/Refused to Report Race and Ethnicity 10.43% 17.46%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 4,183
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 88.02%
COVID-19 Immunization Series Completed 4,218
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 88.25%
COVID-19 Immunization Series Additional 552
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 69.31%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 10.30% 10.08% 25.91%
White, Hispanic/Latino Patients 23.21% 23.42% 15.22%
Black/African American, Non-Hispanic/Latino Patients 26.70% 24.85% 30.25%
Black/African American, Hispanic/Latino Patients 0.43% 0.97% 0.00%
Asian Patients3 1.03% 0.92% 1.99%
American Indian/Alaska Native Patients3 1.00% 1.30% 0.54%
Native Hawaiian/Other Pacific Islander Patients3 0.10% 0.12% 0.18%
Patients with More than one race3 1.17% 1.28% 0.18%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 22.07% 22.78% 10.14%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 3.80% 4.01% 4.71%
Unreported/Refused to Report Race and Ethnicity 10.18% 10.27% 10.87%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 8.11%
1 to 24 Hours 24.32%
More Than 24 Hours 67.57%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 2.70%
Staffing to administer the vaccine 18.92%
Vaccine confidence 40.54%
Vaccine storage capacity 2.70%
Vaccine supply 2.70%
Other 13.51%
None 35.14%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 21.62%
Average Percent of Health Center Visits Conducted Virtually 23.65%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 21.62%
Number of Mobile Van Sites 14
Number of Pop-up Clinics 20
Number of School-Based Vaccination Sites 9

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 2.70%
Refer patients to another organization that provides monoclonal antibody therapies 37.84%
None 59.46%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 16.22%
Patient awareness/education 8.11%
Staffing capacity 24.32%
Therapy administration/onsite logistics 24.32%
Other 8.11%
None 40.54%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021